Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

CASY Q2 Earnings Beat Estimates, Inside Sales Rise Y/Y, FY26 View Up
CASY Q2 Earnings Beat Estimates, Inside Sales Rise Y/Y, FY26 View Up

Casey's General Stores, Inc. CASY reported second-quarter fiscal 2026 results, wherein the top line lagged the Zacks Consensus Estimate and the bottom line missed the same. Both metrics increased

Can Burlington Stores' Expansion Pipeline Accelerate 2026 Growth?
Can Burlington Stores' Expansion Pipeline Accelerate 2026 Growth?

Burlington Stores, Inc.’s BURL expanding pipeline of new locations signals confidence in sustaining its accelerated growth into 2026. With strong store additions, opportunistic lease acquisitions

RR Stock Soars 114% in 6 Months: Time to Chase or Hold Back?
RR Stock Soars 114% in 6 Months: Time to Chase or Hold Back?

Richtech Robotics Inc. RR shares have shown remarkable growth over the past six months. It has surged 113.8% during the period, outperforming the 17.4% rise of its industry and the 17% growth of the

How Lemonade's Investment Income Shapes Its Financial Health
How Lemonade's Investment Income Shapes Its Financial Health

Lemonade Inc.’s LMND top line, like any other insurer, has net investment income as an important component, complementing premium revenues as well as commission and other income.LMND’s net

WFC to Reshape Its Workforce for AI Era, Signals More Job Cuts in 2026
WFC to Reshape Its Workforce for AI Era, Signals More Job Cuts in 2026

At the Goldman Sachs 2025 conference held on Dec. 9, Wells Fargo & Company WFC signaled that its workforce could shrink further in 2026 as part of a broader push to improve efficiency and

SGU Posts Narrower Y/Y Q4 Loss as Acquisitions & Margins Improve
SGU Posts Narrower Y/Y Q4 Loss as Acquisitions & Margins Improve

Shares of Star Group, L.P. SGU have declined 1% since reporting earnings for the fourth quarter of fiscal 2025 compared with the S&P 500 index’s 0.5% fall during the same period. Over the past

AU Stock Soars 266% YTD: What's the Right Strategy for Investors Now?
AU Stock Soars 266% YTD: What's the Right Strategy for Investors Now?

AngloGold Ashanti PLC’s AU stock has rocketed 265.7% year to date, outperforming the Zacks Mining – Gold industry’s 132.7% upsurge. Meanwhile, the Basic Materials sector has risen 27.2%, and the S&P

Here is Why Growth Investors Should Buy Insulet (PODD) Now
Here is Why Growth Investors Should Buy Insulet (PODD) Now

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to

Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"
Is HealthEquity (HQY) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth

Coca-Cola Stock Rallies 12% in a Year: Wise to Buy or Stay Patient?
Coca-Cola Stock Rallies 12% in a Year: Wise to Buy or Stay Patient?

The Coca-Cola Company KO has displayed reasonable strength with 11.9% growth in the past year, outperforming the Beverages – Soft Drinks industry’s 4.9% rally and the Consumer Staples sector’s 5.9%

How to Play Pagaya Stock as It Remains Resilient Through Cycles?
How to Play Pagaya Stock as It Remains Resilient Through Cycles?

Pagaya Technologies PGY has become one of the more stable fintech players in a market still dealing with high interest rates, changing credit conditions and uneven consumer spending. Its artificial

PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor
PLSE Starts Research Work on nPulse Technology to Treat Thyroid Tumor

Pulse Biosciences, Inc. PLSE announced that it initiated a research collaboration with The University of Texas MD Anderson Cancer Center to test its nPulse technology — Vybrance — for treating

Earnings Estimates Moving Higher for Webull Corporation (BULL): Time to Buy?
Earnings Estimates Moving Higher for Webull Corporation (BULL): Time to Buy?

Webull Corporation (BULL) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue

Can Samsara Inc. (IOT) Run Higher on Rising Earnings Estimates?
Can Samsara Inc. (IOT) Run Higher on Rising Earnings Estimates?

Samsara Inc. (IOT) appears an attractive pick given a noticeable improvement in the company's earnings outlook. The stock has been a strong performer lately, and the momentum might continue with

Can Descartes Systems (DSGX) Run Higher on Rising Earnings Estimates?
Can Descartes Systems (DSGX) Run Higher on Rising Earnings Estimates?

Descartes Systems (DSGX) could be a solid addition to your portfolio given a notable revision in the company's earnings estimates. While the stock has been gaining lately, the trend might continue

Fed Watch: Will Jerome Powell Goose the Stock Market?
Fed Watch: Will Jerome Powell Goose the Stock Market?

The Federal Reserve will conclude its most contentious FOMC meeting of the year this afternoon, and the outcome has the potential to meaningfully sway markets. There is a real possibility this turns

3 Key Reasons to Buy Five9 Stock Beyond the 49% Decline in a Year
3 Key Reasons to Buy Five9 Stock Beyond the 49% Decline in a Year

Five9 (FIVN) shares have declined 49.1% in the trailing 12 months, significantly underperforming the Zacks Computer and Technology sector's return of 27.3% and the Zacks Internet Software industry's

Is it Wise to Retain Macerich Stock in Your Portfolio Now?
Is it Wise to Retain Macerich Stock in Your Portfolio Now?

The Macerich Company MAC is well-poised to gain from its portfolio of premium shopping centers in vibrant markets. Its focus on omnichannel retailing and developing mixed-use assets is likely to

What Makes Rentokil Initial (RTO) a New Buy Stock
What Makes Rentokil Initial (RTO) a New Buy Stock

Rentokil Initial PLC (RTO) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Xperi (XPER) Upgraded to Strong Buy: Here's What You Should Know
Xperi (XPER) Upgraded to Strong Buy: Here's What You Should Know

Investors might want to bet on Xperi (XPER), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of

Cap Gemini (CGEMY) Upgraded to Buy: Here's Why
Cap Gemini (CGEMY) Upgraded to Buy: Here's Why

Cap Gemini SA (CGEMY) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting

BB Seguridade Participacoes (BBSEY) Upgraded to Buy: Here's What You Should Know
BB Seguridade Participacoes (BBSEY) Upgraded to Buy: Here's What You Should Know

Investors might want to bet on BB Seguridade Participacoes SA (BBSEY), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful

Byrna Technologies (BYRN) Upgraded to Buy: What Does It Mean for the Stock?
Byrna Technologies (BYRN) Upgraded to Buy: What Does It Mean for the Stock?

Byrna Technologies Inc. (BYRN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --

Are You Looking for a Top Momentum Pick? Why Cirrus Logic (CRUS) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Cirrus Logic (CRUS) is a Great Choice

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell

Ciena (CIEN) Upgraded to Buy: Here's What You Should Know
Ciena (CIEN) Upgraded to Buy: Here's What You Should Know

Ciena (CIEN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one of the most